New Class of Antibiotics Effective Against Drug-resistant Tuberculosis
A new class of antibiotics is highly effective against drug-resistant tuberculosis and, if validated, would represent a major advance in the treatment of TB.
A new class of antibiotics is highly effective against drug-resistant tuberculosis and, if validated, would represent a major advance in the treatment of TB.
Researchers have discovered that the antibiotic doxycycline, in combination with TB drug treatment, reduces the size of lung cavities.
A study of more than 22,000 people in South Africa found that patients with tuberculosis or HIV had a greater risk of death from COVID-19 compared to non-TB/non-HIV COVID-19 patients.
Seven million people were diagnosed and treated for tuberculosis in 2018 — a more than 9%...
Read MoreA Rutgers New Jersey Medical School study has found a genetically tractable cause of drug tolerant tuberculosis, paving the way for researchers to develop new drugs to combat the global TB epidemic and cure the disease....
Read MoreAn unlikely bidding war has erupted over a former tuberculosis sanatorium in upstate New York that has been abandoned for nearly half a century, reports Fox News. In recent days, online haggling for Saratoga County Homestead in...
Read MoreMore than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of...
Read MoreHigher daily doses of rifampin killed more TB bacteria in sputum cultures and the higher doses did so without increasing the adverse effects of treatment.
Read MoreA new blood test has been found to more accurately predict the development of tuberculosis up to two years before its onset in people living with someone with active TB.
Read MoreA new report on tuberculosis (TB) published by The Economist Intelligence Unit investigates the increasing health challenges posed by TB and calls for new ways to improve the effectiveness of the global response to this pandemic.
Read MoreResearchers are developing a new model for multidrug-resistant tuberculosis drugs using the molecular structure of pyridomycin.
Read MoreA new device uses the space-tested concept of capillary flow to diagnose infectious diseases such as HIV/AIDS and tuberculosis.
Read MoreA drug under clinical trials to treat tuberculosis could be the basis for a class of broad-spectrum drugs that act against various bacteria, fungal infections and parasites, yet evade resistance,
Read MoreResearchers from Brigham and Women’s Hospital and Harvard Medical School estimate the number of childhood TB cases is double previous estimates: about 1 million annually with 32,000 suffering from multidrug-resistant TB.
Read MoreTB rates in the country fell from 170 to 59 per 100,000 people after increased awareness of the directly observed, treatment short-course (DOTS) tuberculosis control strategy, according to researchers.
Read More